Marshall Wace’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-44,066
Closed -$1.24M 3494
2025
Q3
$1.24M Buy
+44,066
New +$1.33M ﹤0.01% 1853
2025
Q2
Sell
-318,188
Closed -$12.5M 3191
2025
Q1
$12.5M Sell
318,188
-527,919
-62% -$23.8M 0.02% 684
2024
Q4
$39.3M Buy
846,107
+840,828
+15,928% +$38M 0.05% 337
2024
Q3
$239K Buy
+5,279
New +$251K ﹤0.01% 2239
2023
Q4
Sell
-220,572
Closed -$4.47M 2623
2023
Q3
$4.47M Sell
220,572
-680,892
-76% -$15M 0.01% 916
2023
Q2
$18.4M Buy
901,464
+541,327
+150% +$8.11M 0.04% 508
2023
Q1
$5.43M Sell
360,137
-418,065
-54% -$9.24M 0.01% 959
2022
Q4
$18.5M Sell
778,202
-417,195
-35% -$12.1M 0.04% 481
2022
Q3
$42.1M Sell
1,195,397
-864,193
-42% -$36.7M 0.09% 238
2022
Q2
$72M Buy
2,059,590
+362,695
+21% +$12.8M 0.15% 140
2022
Q1
$83.8M Buy
1,696,895
+443,347
+35% +$24.6M 0.16% 136
2021
Q4
$97M Buy
1,253,548
+305,058
+32% +$31.3M 0.18% 104
2021
Q3
$101M Sell
948,490
-63,363
-6% -$7.26M 0.42% 27
2021
Q2
$135M Buy
1,011,853
+157,341
+18% +$18.3M 0.61% 16
2021
Q1
$106M Buy
854,512
+326,930
+62% +$49.6M 0.49% 29
2020
Q4
$74.5M Sell
527,582
-59,372
-10% -$6.59M 0.4% 46
2020
Q3
$44.6M Buy
586,954
+514,071
+705% +$32M 0.29% 78
2020
Q2
$3.3M Buy
+72,883
New +$2.62M 0.02% 607

Other funds holding TWST

Marshall Wace's TWST Position: Q4 2025 in Review

Marshall Wace sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 44,066 shares — an estimated $1.24M sold.

Marshall Wace first reported a position in TWST in Q2 2020 and held it in 18 quarters. The position peaked at $135M in Q2 2021. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Marshall Wace reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 44,066 Twist Bioscience shares in Q4 2025, an estimated $1.24M.
  • Marshall Wace first reported a position in Twist Bioscience in Q2 2020 and held it in 18 quarters.
  • Marshall Wace's Twist Bioscience position peaked at $135M in Q2 2021.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.